1Ilson DH. Oesophageal caneer: new developments in systemic therapy [J]. Cancer Treat Rev,2003,29(6) :525 -532.
2Anderson SE ,Minsky BD, Bains M ,et al. Combined modality therapy in esophageal cancer: the Memorial experience [ J]. Semin Surg Oncol, 2003,21 (4) : 228 - 232.
3Scheithauer W. Esophageal cancer: chemotherapy as palliative therapy [ J ]. Ann Oncol,2004,15 ( Suppl 4) : iv 97 - iv 100.
4Koshy M, Esiashvilli N, Landry JC, et al. Multiple management modal- ities in esophageal cancer: combined modality management approaches [ J ]. Oncologist, 2004,9 ( 2 ) : 147 - 159.
5Westerterp M, Koppert LB, Buskens C J, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction [ J ]. Virchows Arch, 2005,446 ( 5 ) : 497 - 504.
8Kaklamanos IG,Walker GR, Ferry K, et al. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials [ J ]. Ann Surg Oncol, 2003,10(7) :754 -761.
9Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer [ J]. Am J Surg,2002, 183(3) :274 -279.
8Lerut T, De Leyn P, Coosemans W, et al, Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg, 1992, 216:583-590.
9Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg, 1994, 220:364-373.
